RxDoctor Payments Data

Sharon Brown

Family · Blue Ridge, GANPI 1710098413

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.3% of the total across 209 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Novartis at 28.4% of the total. Among family clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,070in general payments, 2019–2025

Across 209 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Sun Pharmaceutical Industries Inc.$698
  • AbbVie$563
  • Regeneron Healthcare Solutions, Inc.$416
  • Johnson & Johnson$301
  • Sanofi$201
  • plus $733 from 15 others

What the payments were for

  • Food & beverage$3,83794%
  • Education$2336%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,070 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia →

Medicare billing

Part B allowed, 2024
$114,765
Medicare patients
855
Services billed
2,641

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab36$276,771
Dupixent PenDupilumab36$136,882
Dupixent SyringeDupilumab22$84,089
Fluorouracil44$2,899
Clobetasol Propionate55$2,088
Metronidazole33$1,907
Ketoconazole138$1,703
Doxycycline Hyclate72$1,481
Triamcinolone Acetonide98$1,129
Mupirocin31$292
Clindamycin Phosphate11$256

Paid to pharmacies, not to this prescriber.

Other family in Blue Ridge

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →